EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acute treatment of migraine: quantifying the unmet need through real-world data in Italy

Simona Sacco, Sonia Di Ciaccio, Roberto Di Virgilio, Valeria Pegoraro, Raffaele Ornello

Neurological Sciences · 2024

DOI: 10.1007/s10072-024-07493-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2024. Verfasst von Simona Sacco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Hauptthemen laut MEDLINE: Migraine Disorders, Tryptamines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer S.r.l..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study is describing subjects with migraine interrupting or not receiving triptans for acute treatment and providing a national-level estimate of people who might benefit from different therapeutic approaches.

Methods

This is a retrospective analysis using IQVIA Longitudinal Patient Database. Starting from 18 + years old individuals with migraine, we selected two cohorts: subjects with triptans prescriptions before and no triptans prescriptions after Index Date (triptan withdraw) and subjects without triptans prescriptions both before and after Index Date (no triptan prescriptions). Index Date was the first record of a health encounter for migraine in 2019. Individuals with cardiovascular disease (CVD) within no triptan prescriptions group were also quantified.

Results

Triptan withdraw and no triptan prescriptions cohorts numbered 605 and 3270, respectively, 5% and 29% of subjects with migraine. Mean age was 47 and 51 years respectively; women were more represented (~ 80%). Hypertension and thyroid disease were most frequent comorbidities; non-steroidal anti-inflammatory drugs were among most frequently recorded treatments. Subjects with CVD within no triptan prescriptions cohort were 621 and with triptan withdraw cohort subjects represented the basis to estimate those who might benefit from alternative options for the acute treatment of migraine, who were around 60,000 and accounted for 11% of subjects seeking primary care due to migraine.

Conclusions

This analysis provides a real-word estimate of Italian people that might benefit from different therapeutic approaches as an alternative to triptans, which sometimes might be not effective and/or poorly tolerated. Such estimate should be intended as the lower limit of a wider range due to strict criteria adopted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersTryptaminesHumansFemaleMaleItalyMiddle AgedRetrospective StudiesAdultYoung AdultAdolescentLongitudinal StudiesDatabases, FactualAgedCardiovascular Diseases

Stichwörter der Autor:innen

ContraindicationsMigrainePoor effectivenessPoor tolerabilityReal-world evidenceTriptansUnmet need

Substanzen

Tryptamines

Autor:innen und Institutionen

  • Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Medical Department, Pfizer Srl, Rome, Italy.
  • Health Economics and Outcome Research Department, Pfizer Srl, Rome, Italy.
  • RWS Department, IQVIA Solutions Italy S.R.L, Via Fabio Filzi 29, 20124, Milan, Italy. valeria.pegoraro@iqvia.com.

Förderung

  • Pfizer S.r.l.

Zitieren

APA

Sacco, S., Di Ciaccio, S., Di Virgilio, R., Pegoraro, V., & Ornello, R. (2024). Acute treatment of migraine: quantifying the unmet need through real-world data in Italy. Neurological Sciences. https://doi.org/10.1007/s10072-024-07493-w

Vancouver

Sacco S, Di Ciaccio S, Di Virgilio R, Pegoraro V, Ornello R. Acute treatment of migraine: quantifying the unmet need through real-world data in Italy. Neurological Sciences. 2024. doi:10.1007/s10072-024-07493-w

BibTeX
@article{Sacco2024,
  author = {Sacco, Simona and Di Ciaccio, Sonia and Di Virgilio, Roberto and Pegoraro, Valeria and Ornello, Raffaele},
  title = {Acute treatment of migraine: quantifying the unmet need through real-world data in Italy},
  journal = {Neurological Sciences},
  year = {2024},
  doi = {10.1007/s10072-024-07493-w}
}
Kostenlos starten →